Five-year outcomes following complex reconstructive surgery for infective endocarditis involving the intervalvular fibrous body

25Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

OBJECTIVES: Destruction of the intervalvular fibrous body (IFB) due to infective endocarditis (IE) warrants a complex operation involving radical debridement of all infected tissue, followed by double valve replacement (aortic and mitral valve replacement) with patch reconstruction of the IFB. This study assesses the 5-year outcomes in patients undergoing this complex procedure for treatment of double valve IE with IFB involvement. METHODS: A total of 127 consecutive patients underwent double valve replacement with reconstruction of the IFB for active complex IE between January 1999 and December 2018. Primary outcomes were 3-year and 5-year survival, as well as 5-year freedom from reoperation. RESULTS: Patients' mean age was 65.3 ± 12.9 years. Preoperative cardiogenic shock and sepsis were present in 17.3% and 18.9%, respectively. The majority of patients (81.3%) had undergone previous cardiac surgery. Overall, 30-day and 90-day mortality rates were 28.3% and 37.0%, respectively. The 3- and 5-year survival rates for all patients were 45.3 ± 5.1% and 41.8 ± 5.8%, and for those who survived the first 90 postoperative days 75.8 ± 6.1% and 70.0 ± 8.0%, respectively. The overall 5-year freedom from reoperation was 85.1 ± 5.7%. Preoperative predictors for 30-day mortality were Staphylococcus aureus [odds ratio (OR) 1.65; P = 0.04] and left ventricular ejection fraction (LVEF) <35% (OR 12.06; P = 0.03), for 90-day mortality acute kidney injury requiring dialysis (OR 6.2; P = 0.02) and LVEF <35% (OR 9.66; P = 0.03) and for long-term mortality cardiogenic shock (hazard ratio 2.46; P = 0.01). CONCLUSIONS: Double valve replacement with reconstruction of the IFB in patients with complex IE is a challenging operation associated with high morbidity and mortality, particularly in the first 90 days after surgery. Survival and freedom from reoperation rates are acceptable thereafter, particularly considering the severity of disease and complex surgery.

References Powered by Scopus

2015 ESC Guidelines for the management of infective endocarditis

3837Citations
N/AReaders
Get full text

Transesophageal echocardiographic recognition of subaortic complications in aortic valve endocarditis: Clinical and surgical implications

294Citations
N/AReaders
Get full text

Early surgery in patients with infective endocarditis: A propensity score analysis

185Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Surgical aortic mitral curtain replacement: Systematic review and metanalysis of early and long-term results

18Citations
N/AReaders
Get full text

Outcomes of combined aortic and mitral valve replacement with reconstruction of the fibrous skeleton of the heart

12Citations
N/AReaders
Get full text

Endocarditis in patients with aortic valve prosthesis: Comparison between surgical and transcatheter prosthesis

10Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Davierwala, P. M., Marin-Cuartas, M., Misfeld, M., Deo, S. V., Lehmann, S., Garbade, J., … Bakhtiary, F. (2020). Five-year outcomes following complex reconstructive surgery for infective endocarditis involving the intervalvular fibrous body. European Journal of Cardio-Thoracic Surgery, 58(5), 1080–1087. https://doi.org/10.1093/EJCTS/EZAA146

Readers over time

‘20‘21‘22‘23‘24‘250481216

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

63%

Professor / Associate Prof. 2

25%

Researcher 1

13%

Readers' Discipline

Tooltip

Medicine and Dentistry 11

92%

Decision Sciences 1

8%

Save time finding and organizing research with Mendeley

Sign up for free
0